Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases
Yıl: 2021 Cilt: 43 Sayı: 6 Sayfa Aralığı: 585 - 593 Metin Dili: İngilizce DOI: 10.14744/etd.2021.88122 İndeks Tarihi: 19-02-2022
Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases
Öz: Objective: The present study aims to compare the clinical and laboratory characteristics of patients diagnosed with coronavirus disease (COVID-19) using Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and Computed Tomography (CT). Materials and Methods: In this study, 240 adult patients were included. The demographic data, symptoms, COVID-19 findings in the initial pulmonary CT during admission and the first laboratory parameters were recorded. The patients were divided into three groups as Group 1 consisting of 100 PCR (+) CT (+) patients, Group 2 consisting of 40 PCR (+) CT (-) patients, Group 3 consisting of 100 PCR (-) CT (+) patients. Results: The mean symptom duration was 5.78 days in Group 1, 2.67 days in Group 2, and 5.26 days in Group 3 (p<0.05). The mean symptom duration was 5.52 days in CT (+) patients and 2.67 days in CT (-) patients (p<0.05). The findings showed that one unit increase in pathological lobe count decreased PCR positivity by 1.3 times (p=0.002). Conclusion: There may not be any findings in CT in the first 48-72 hours after the onset of the symptoms in symptomatic patients, and as the number of pathological pulmonary lobes detected in CT increases, PCR positivity decreases.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497–506.
- 2. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020; 55(3): 105924.
- 3. Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg 2020; 78: 185–93
- 4. Yang Y, Yang M, Shen C, Wang F, Yuan J, Li J, et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. MedRxiv February 17, 2020. doi: 10.1101/2020.02.11.20021493.
- 5. Aktas, Gulali. A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection. Exp Biomed Res 2020; 3(4): 293–311.
- 6. Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 2020; 295(1): 202–7.
- 7. Huang P, Liu T, Huang L, Liu H, Lei M, Xu W, et al. Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion. Radiology 2020; 295(1): 22–3.
- 8. Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest CT for typical coronavirus disease 2019 (COVID-19) pneumonia: Relationship to negative RT-PCR testing. Radiology 2020; 296(2): E41–5.
- 9. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology 2020; 296(2): E32–40.
- 10. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395(10229): 1033–4.
- 11. Wang L. C-reactive protein levels in the early stage of COVID-19. Med Mal Infect 2020; 50(4): 332–4.
- 12. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 2020; 84: 106504.
- 13. Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chim Acta 2020; 505: 190–1.
- 14. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID-19. Am J Hematol 2020; 95(7): 834–47.
- 15. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis 2020; 63(3): 390–1.
- 16. World Health Organization. Public health surveillance for COVID-19: interim guidance. 16 Dec 2020. WHO reference number: WHO/2019- nCoV/SurveillanceGuidance/2020.8.
- 17. An P, Song P, Wang Y, Liu B. Asymptomatic patients with novel coronavirus disease (COVID-19). Balkan Med J 2020;37:229–30.
- 18. He JL, Luo L, Luo ZD, Lyu JX, Ng MY, Shen XP, et al. Diagnostic performance between CT and initial real-time RT-PCR for clinically suspected 2019 coronavirus disease (COVID-19) patients outside Wuhan, China. Respir Med 2020; 168: 105980.
- 19. Shimoyama Y, Umegaki O, Inoue S, Agui T, Kadono N, Minami T. The neutrophil to lymphocyte ratio ıs superior to other ınflammation-based prognostic scores in predicting the mortality of patients with pneumonia. Acta Med Okayama 2018; 72: 591–3.
- 20. Duman TT, Aktas G, Atak BM, Kocak MZ, Erkus E, Savli H. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci 2019; 19(1): 1602–6.
- 21. Aktas G, Sit M, Dikbas O, Erkol H, Altinordu R, Erkus E, et al. Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto’s thyroiditis. Rev Assoc Med Bras (1992) 2017; 63(12): 1065–8.
- 22. Sit M, Aktas G, Erkol H, Yaman S, Keyif F, Savli H. Neutrophil to lymphocyte ratio is useful in differentiation of malign and benign thyroid nodules. P R Health Sci J 2019; 38(1): 60–3.
- 23. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18(4): 844–7.
| APA | Gündoğdu O, Avcı O (2021). Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases. , 585 - 593. 10.14744/etd.2021.88122 |
| Chicago | Gündoğdu Oğuz,Avcı Onur Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases. (2021): 585 - 593. 10.14744/etd.2021.88122 |
| MLA | Gündoğdu Oğuz,Avcı Onur Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases. , 2021, ss.585 - 593. 10.14744/etd.2021.88122 |
| AMA | Gündoğdu O,Avcı O Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases. . 2021; 585 - 593. 10.14744/etd.2021.88122 |
| Vancouver | Gündoğdu O,Avcı O Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases. . 2021; 585 - 593. 10.14744/etd.2021.88122 |
| IEEE | Gündoğdu O,Avcı O "Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases." , ss.585 - 593, 2021. 10.14744/etd.2021.88122 |
| ISNAD | Gündoğdu, Oğuz - Avcı, Onur. "Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases". (2021), 585-593. https://doi.org/10.14744/etd.2021.88122 |
| APA | Gündoğdu O, Avcı O (2021). Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases. Erciyes Medical Journal, 43(6), 585 - 593. 10.14744/etd.2021.88122 |
| Chicago | Gündoğdu Oğuz,Avcı Onur Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases. Erciyes Medical Journal 43, no.6 (2021): 585 - 593. 10.14744/etd.2021.88122 |
| MLA | Gündoğdu Oğuz,Avcı Onur Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases. Erciyes Medical Journal, vol.43, no.6, 2021, ss.585 - 593. 10.14744/etd.2021.88122 |
| AMA | Gündoğdu O,Avcı O Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases. Erciyes Medical Journal. 2021; 43(6): 585 - 593. 10.14744/etd.2021.88122 |
| Vancouver | Gündoğdu O,Avcı O Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases. Erciyes Medical Journal. 2021; 43(6): 585 - 593. 10.14744/etd.2021.88122 |
| IEEE | Gündoğdu O,Avcı O "Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases." Erciyes Medical Journal, 43, ss.585 - 593, 2021. 10.14744/etd.2021.88122 |
| ISNAD | Gündoğdu, Oğuz - Avcı, Onur. "Comparing the Clinical, Radiological and Laboratory Characteristics of Confirmed or Suspected COVID-19 Cases". Erciyes Medical Journal 43/6 (2021), 585-593. https://doi.org/10.14744/etd.2021.88122 |
